PROPULSID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Propulsid, and what generic alternatives are available?
Propulsid is a drug marketed by Janssen Pharms and Janssen Pharma and is included in three NDAs.
The generic ingredient in PROPULSID is cisapride monohydrate. There are two drug master file entries for this compound. Additional details are available on the cisapride monohydrate profile page.
Summary for PROPULSID
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 42 |
Clinical Trials: | 1 |
Patent Applications: | 3,543 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PROPULSID at DailyMed |
Recent Clinical Trials for PROPULSID
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Temple University | N/A |
American College of Gastroenterology | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for PROPULSID
US Patents and Regulatory Information for PROPULSID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Janssen Pharms | PROPULSID | cisapride monohydrate | SUSPENSION;ORAL | 020398-001 | Sep 15, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Janssen Pharma | PROPULSID QUICKSOLV | cisapride monohydrate | TABLET, ORALLY DISINTEGRATING;ORAL | 020767-001 | Nov 7, 1997 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Janssen Pharms | PROPULSID | cisapride monohydrate | TABLET;ORAL | 020210-001 | Jul 29, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Janssen Pharms | PROPULSID | cisapride monohydrate | TABLET;ORAL | 020210-002 | Dec 23, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PROPULSID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Janssen Pharms | PROPULSID | cisapride monohydrate | TABLET;ORAL | 020210-002 | Dec 23, 1993 | ⤷ Try a Trial | ⤷ Try a Trial |
Janssen Pharms | PROPULSID | cisapride monohydrate | SUSPENSION;ORAL | 020398-001 | Sep 15, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Janssen Pharms | PROPULSID | cisapride monohydrate | TABLET;ORAL | 020210-001 | Jul 29, 1993 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PROPULSID
See the table below for patents covering PROPULSID around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Kenya | 3828 | NOVEL N-(3-HYDROXY-4-PIPERIDINYL)BENZAMIDE DERIVATIVES | ⤷ Try a Trial |
Yugoslavia | 219082 | ⤷ Try a Trial | |
Australia | 8892582 | ⤷ Try a Trial | |
Latvia | 5044 | N-(3-hidroksi-4-piperidinil-)benzamida atvasinajumu vai to skabju-aditivo salu iegusanas metode | ⤷ Try a Trial |
Spain | 8603413 | "PROCEDIMIENTO PARA LA OBTENCION DE LA CIS-4-AMINO-5-CLORO-2-METO-XI-N-(1-(3-(4-FLUOROFENOXI)PROPIL)-3-METOXI-4-PIPERI- DIL)BENZAMIDA" (Piperidyl-benzamide deriv. - for use in synthesis of pharmacological prods. Piperidyl-benzamide deriv.) | ⤷ Try a Trial |
Norway | 823297 | ⤷ Try a Trial | |
Greece | 76911 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for PROPULSID
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0076530 | SPC/GB93/037 | United Kingdom | ⤷ Try a Trial | |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |